WallStreetZenWallStreetZen

NASDAQ: SXTP
60 Degrees Pharmaceuticals Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Be the first to know when Wall Street analysts revise their SXTP stock forecasts and price targets.

Forecast return on equity

Is SXTP forecast to generate an efficient return?

Company
-17.15%
Industry
85.14%
Market
61.59%
SXTP's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is SXTP forecast to generate an efficient return on assets?

Company
-12.02%
Industry
23.59%
SXTP is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

SXTP earnings per share forecast

What is SXTP's earnings per share in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
-$2.15
Avg 2 year Forecast
-$0.73
Avg 3 year Forecast
-$0.47

SXTP revenue forecast

What is SXTP's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$1.2M+77.59%
Avg 2 year Forecast
$2.5M+269.86%
Avg 3 year Forecast
$3.8M+454.79%
SXTP's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

SXTP revenue growth forecast

How is SXTP forecast to perform vs Biotechnology companies and vs the US market?

Company
91.68%
Industry
149.96%
Market
10.5%
SXTP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
SXTP's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

SXTP vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
SXTP$2.55N/AN/A
CDT$0.56N/AN/A
TCRT$2.38N/AN/A
MBIO$1.17N/AN/A
SILO$0.81N/AN/A
View Top Biotech Stocks

60 Degrees Pharmaceuticals Stock Forecast FAQ

What is SXTP's earnings growth forecast for 2025-2027?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's forecast annual earnings growth rate of N/A is not forecast to beat the US Biotechnology industry's average forecast earnings growth rate of 16.35%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 22.38%.

60 Degrees Pharmaceuticals's earnings in 2025 is -$8,430,498.On average, 1 Wall Street analyst forecast SXTP's earnings for 2025 to be -$3,166,716, with the lowest SXTP earnings forecast at -$3,166,716, and the highest SXTP earnings forecast at -$3,166,716. On average, 1 Wall Street analyst forecast SXTP's earnings for 2026 to be -$1,075,210, with the lowest SXTP earnings forecast at -$1,075,210, and the highest SXTP earnings forecast at -$1,075,210.

In 2027, SXTP is forecast to generate -$692,259 in earnings, with the lowest earnings forecast at -$692,259 and the highest earnings forecast at -$692,259.

If you're new to stock investing, here's how to buy 60 Degrees Pharmaceuticals stock.

What is SXTP's revenue growth forecast for 2025-2027?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's forecast annual revenue growth rate of 91.68% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 149.96%, and while it is forecast to beat the US market's average forecast revenue growth rate of 10.5%.

60 Degrees Pharmaceuticals's revenue in 2025 is $681,345.On average, 1 Wall Street analysts forecast SXTP's revenue for 2025 to be $1,782,198, with the lowest SXTP revenue forecast at $1,782,198, and the highest SXTP revenue forecast at $1,782,198. On average, 1 Wall Street analysts forecast SXTP's revenue for 2026 to be $3,711,685, with the lowest SXTP revenue forecast at $3,711,685, and the highest SXTP revenue forecast at $3,711,685.

In 2027, SXTP is forecast to generate $5,567,528 in revenue, with the lowest revenue forecast at $5,567,528 and the highest revenue forecast at $5,567,528.

What is SXTP's forecast return on assets (ROA) for 2025-2027?

(NASDAQ: SXTP) forecast ROA is -12.02%, which is lower than the forecast US Biotechnology industry average of 23.59%.

What is SXTP's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: SXTP) 60 Degrees Pharmaceuticals's current Earnings Per Share (EPS) is -$18.55. On average, analysts forecast that SXTP's EPS will be -$2.15 for 2025, with the lowest EPS forecast at -$2.15, and the highest EPS forecast at -$2.15. On average, analysts forecast that SXTP's EPS will be -$0.73 for 2026, with the lowest EPS forecast at -$0.73, and the highest EPS forecast at -$0.73. In 2027, SXTP's EPS is forecast to hit -$0.47 (min: -$0.47, max: -$0.47).

What is SXTP's forecast return on equity (ROE) for 2025-2027?

(NASDAQ: SXTP) forecast ROE is -17.15%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.